Search Results - "Jones, Robert H"

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer by Glaviano, Antonino, Foo, Aaron S C, Lam, Hiu Y, Yap, Kenneth C H, Jacot, William, Jones, Robert H, Eng, Huiyan, Nair, Madhumathy G, Makvandi, Pooyan, Geoerger, Birgit, Kulke, Matthew H, Baird, Richard D, Prabhu, Jyothi S, Carbone, Daniela, Pecoraro, Camilla, Teh, Daniel B L, Sethi, Gautam, Cavalieri, Vincenzo, Lin, Kevin H, Javidi-Sharifi, Nathalie R, Toska, Eneda, Davids, Matthew S, Brown, Jennifer R, Diana, Patrizia, Stebbing, Justin, Fruman, David A, Kumar, Alan P

“…The PI3K/AKT/mTOR (PAM) signaling pathway is a highly conserved signal transduction network in eukaryotic cells that promotes cell survival, cell growth, and…”
Get full text

Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction by Bonow, Robert O, Maurer, Gerald, Lee, Kerry L, Holly, Thomas A, Binkley, Philip F, Desvigne-Nickens, Patrice, Drozdz, Jaroslaw, Farsky, Pedro S, Feldman, Arthur M, Doenst, Torsten, Michler, Robert E, Berman, Daniel S, Nicolau, Jose C, Pellikka, Patricia A, Wrobel, Krzysztof, Alotti, Nasri, Asch, Federico M, Favaloro, Liliana E, She, Lilin, Velazquez, Eric J, Jones, Robert H, Panza, Julio A

“…Patients with CAD and LV dysfunction were assigned to receive either medical therapy alone or medical therapy plus CABG. There was no evidence of significant…”
Get full text

Immune cell status, cardiorespiratory fitness and body composition among breast cancer survivors and healthy women: a cross sectional study by Arana Echarri, Ainhoa, Struszczak, Lauren, Beresford, Mark, Campbell, John P, Jones, Robert H, Thompson, Dylan, Turner, James E

“…We examined whether immune cell profiles differ between healthy women ( = 38) and breast cancer survivors ( = 27) within 2 years of treatment, and whether any…”
Get full text

Drug-Eluting Stents vs. Coronary-Artery Bypass Grafting in Multivessel Coronary Disease by Hannan, Edward L, Wu, Chuntao, Walford, Gary, Culliford, Alfred T, Gold, Jeffrey P, Smith, Craig R, Higgins, Robert S.D, Carlson, Russell E, Jones, Robert H

“…In this New York State registry study, outcomes of patients with multivessel coronary disease treated with drug-eluting coronary stents or coronary-artery…”
Get full text

Inducible Myocardial Ischemia and Outcomes in Patients With Coronary Artery Disease and Left Ventricular Dysfunction by Panza, Julio A., MD, Holly, Thomas A., MD, Asch, Federico M., MD, She, Lilin, PhD, Pellikka, Patricia A., MD, Velazquez, Eric J., MD, Lee, Kerry L., PhD, Borges-Neto, Salvador, MD, Farsky, Pedro S., MD, Jones, Robert H., MD, Berman, Daniel S., MD, Bonow, Robert O., MD

“…Objectives The study objectives were to test the hypotheses that ischemia during stress testing has prognostic value and identifies those patients with…”
Get full text

Influence of Mitral Regurgitation Repair on Survival in the Surgical Treatment for Ischemic Heart Failure Trial by DEJA, Marek A, GRAYBURN, Paul A, MOKRZYCKI, Krzysztof, MENICANTI, Lorenzo, OH, Jae K, MICHLER, Robert, WROBEL, Krzysztof, LAMY, Andre, VELAZQUEZ, Eric J, LEE, Kerry L, JONES, Robert H, BENJAMIN SUN, VIVEK RAO, LILIN SHE, KREJCA, Michał, JAIN, Anil R, YEOW LENG CHUA, DALY, Richard, SENNI, Michele

“…Whether mitral valve repair during coronary artery bypass grafting (CABG) improves survival in patients with ischemic mitral regurgitation (MR) remains…”
Get full text

Insights from the STICH trial: Change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction by Michler, Robert E., MD, Rouleau, Jean L., MD, Al-Khalidi, Hussein R., PhD, Bonow, Robert O., MD, Pellikka, Patricia A., MD, Pohost, Gerald M., MD, Holly, Thomas A., MD, Oh, Jae K., MD, Dagenais, Francois, MD, Milano, Carmelo, MD, Wrobel, Krzysztof, MD, Pirk, Jan, MD, DSc, Ali, Imtiaz S., MD, Jones, Robert H., MD, Velazquez, Eric J., MD, Lee, Kerry L., PhD, Di Donato, Marisa, MD

“…Objective The present analysis of the Surgical Treatment for Ischemic Heart Failure randomized trial data examined the left ventricular volumes at baseline and…”
Get full text

Long-Term Outcomes of Coronary-Artery Bypass Grafting versus Stent Implantation by Hannan, Edward L, Racz, Michael J, Walford, Gary, Jones, Robert H, Ryan, Thomas J, Bennett, Edward, Culliford, Alfred T, Isom, O. Wayne, Gold, Jeffrey P, Rose, Eric A

“…Using data derived from two large New York State registries, this study compared three-year survival rates among patients with multivessel coronary disease who…”
Get full text

Extent of Coronary and Myocardial Disease and Benefit From Surgical Revascularization in LV Dysfunction by Panza, Julio A., MD, Velazquez, Eric J., MD, She, Lilin, PhD, Smith, Peter K., MD, Nicolau, José C., MD, Favaloro, Roberto R., MD, Gradinac, Sinisa, MD, Chrzanowski, Lukasz, MD, Prabhakaran, Dorairaj, MD, Howlett, Jonathan G., MD, Jasinski, Marek, MD, Hill, James A., MD, Szwed, Hanna, MD, Larbalestier, Robert, MD, Desvigne-Nickens, Patrice, MD, Jones, Robert H., MD, Lee, Kerry L., PhD, Rouleau, Jean L., MD

“…Abstract Background Patients with ischemic left ventricular dysfunction have higher operative risk with coronary artery bypass graft surgery (CABG). However,…”
Get full text

Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era by HANNAN, Edward L, RACZ, Michael, HOLMES, David R, KING, Spencer B, WALFORD, Gary, AMBROSE, John A, SHARMA, Samin, KATZ, Stanley, CLARK, Luther T, JONES, Robert H

“…The importance of completeness of revascularization by percutaneous coronary intervention in patients with multivessel disease is unclear in that there is…”
Get full text

The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial by Velazquez, Eric J., MD, FACC, Lee, Kerry L., PhD, O’Connor, Christopher M., MD, FACC, Oh, Jae K., MD, FACC, Bonow, Robert O., MD, FACC, Pohost, Gerald M., MD, FACC, Feldman, Arthur M., MD, PhD, FACC, Mark, Daniel B., MD, MPH, FACC, Panza, Julio A., MD, FACC, Sopko, George, MD, MPH, Rouleau, Jean L., MD, FACC, Jones, Robert H., MD, FACC

“…Objectives The rationale and design of the Surgical Treatment for Ischemic Heart Failure trial is described. Before the Surgical Treatment for Ischemic Heart…”
Get full text

A Phenomic Perspective on Factors Influencing Breast Cancer Treatment: Integrating Aging and Lifestyle in Blood and Tissue Biomarker Profiling by Arana Echarri, Ainhoa, Beresford, Mark, Campbell, John P, Jones, Robert H, Butler, Rachel, Gollob, Kenneth J, Brum, Patricia C, Thompson, Dylan, Turner, James E

“…Breast cancer is the most common malignancy among women worldwide. Over the last four decades, diagnostic and therapeutic procedures have improved…”
Get full text

Longitudinal Assessment of Neurocognitive Function after Coronary-Artery Bypass Surgery by Newman, Mark F, Kirchner, Jerry L, Phillips-Bute, Barbara, Gaver, Vincent, Grocott, Hilary, Jones, Robert H, Mark, Daniel B, Reves, Joseph G, Blumenthal, James A

“…Cognitive decline has increasingly been recognized as a complication after cardiac surgery. Although important advances in techniques for perioperative…”
Get full text

Association of neurocognitive function and quality of life 1 year after coronary artery bypass graft (CABG) surgery by Phillips-Bute, Barbara, Mathew, Joseph P, Blumenthal, James A, Grocott, Hilary P, Laskowitz, Daniel T, Jones, Robert H, Mark, Daniel B, Newman, Mark F

“…Although coronary artery bypass grafting (CABG) has been shown to improve quality of life and functional capacity for many patients, recent studies have…”
Get full text

Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy by Velazquez, Eric J., MD, Williams, Judson B., MD, Yow, Eric, MS, Shaw, Linda K., MS, Lee, Kerry L., PhD, Phillips, Harry R., MD, O'Connor, Christopher M., MD, Smith, Peter K., MD, Jones, Robert H., MD

“…Background We prospectively applied the Surgical Treatment of Ischemic Cardiomyopathy trial entry criteria to an observational database to determine whether…”
Get full text

Propensity Matching Is a Poor Substitute for a Poorly Composed Procedure Note by Jones, Robert H., MD

“…(8) produced data convincing the broad cardiac surgical community that the long-term patency of the ITA bypass was superior to that of saphenous vein. [...]the…”
Get full text

The STICH Trial (Surgical Treatment for Ischemic Heart Failure) by Carson, Peter, MD, Wertheimer, John, MD, Miller, Alan, MD, O'Connor, Christopher M., MD, Pina, Ileana L., MD, Selzman, Craig, MD, Sueta, Carla, MD, She, Lilin, PhD, Greene, Deborah, RN, Lee, Kerry L., PhD, Jones, Robert H., MD, Velazquez, Eric J., MD

“…Objectives This study sought to assess the effect of the addition of coronary artery bypass grafting (CABG) to medical therapy on mode of death in heart…”
Get full text

Risk Index for Predicting In-Hospital Mortality for Cardiac Valve Surgery by Hannan, Edward L., PhD, Wu, Chuntao, MD, PhD, Bennett, Edward V., MD, Carlson, Russell E., MD, Culliford, Alfred T., MD, Gold, Jeffrey P., MD, Higgins, Robert S.D., MD, Smith, Craig R., MD, Jones, Robert H., MD

“…Background Numerous studies have developed a “severity score” or “risk index” for short-term mortality associated with coronary artery bypass graft (CABG)…”
Get full text

Selection of Surgical or Percutaneous Coronary Intervention Provides Differential Longevity Benefit by Smith, Peter K., Califf, Robert M., Tuttle, Robert H., Shaw, Linda K., Lee, Kerry L., Delong, Elizabeth R., Lilly, R. Eric, Sketch, Michael H., Peterson, Eric D., Jones, Robert H.

“…Treatment of coronary artery disease (CAD) is evolving with better medications, improvements in percutaneous coronary intervention (PCI), and enhanced…”
Get full text

A Risk Score to Predict In-Hospital Mortality for Percutaneous Coronary Interventions by Wu, Chuntao, Hannan, Edward L., Walford, Gary, Ambrose, John A., Holmes, David R., King, Spencer B., Clark, Luther T., Katz, Stanley, Sharma, Samin, Jones, Robert H.

“…A Risk Score to Predict In-Hospital Mortality for Percutaneous Coronary Interventions Chuntao Wu, Edward L. Hannan, Gary Walford, John A. Ambrose, David R…”
Get full text